Jeffrey A. Meckler

CEO and Director at Indaptus Therapeutics Inc.

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: Indaptus Therapeutics Inc., 3 years.

Indaptus Therapeutics Inc. Director · Co-Chief Executive Officer
3 years · Since 2023
3 years · Since 2023

Chief executive roles

Indaptus Therapeutics Inc. · CEO and Director
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 10, 2026 Travere Therapeutics Inc. Option exercise +10,000 $17.44 $174,400
Sep 10, 2026 Travere Therapeutics Inc. Option exercise +10,000 $26.52 $265,200
Sep 10, 2026 Travere Therapeutics Inc. Open-market sale −1,700 $65.39 $111,163
Sep 10, 2026 Travere Therapeutics Inc. Open-market sale −1,200 $66.15 $79,380
Sep 10, 2026 Travere Therapeutics Inc. Open-market sale −14,000 $67.46 $944,440
Sep 10, 2026 Travere Therapeutics Inc. Open-market sale −3,100 $68.09 $211,079
May 19, 2026 Travere Therapeutics Inc. Grant or award +4,000 — —
May 4, 2026 Travere Therapeutics Inc. Option exercise +8,000 $16.33 $130,640
May 4, 2026 Travere Therapeutics Inc. Open-market sale −8,000 $45.00 $360,000
Dec 22, 2025 Indaptus Therapeutics Inc. Grant or award +216,617 $2.03 $439,733
Jul 27, 2025 Indaptus Therapeutics Inc. Grant or award +6,068 $8.30 $50,364
May 15, 2025 Travere Therapeutics Inc. Grant or award +6,500 — —
Nov 25, 2024 Indaptus Therapeutics Inc. Grant or award +42,553 $1.18 $50,213
Sep 30, 2024 Travere Therapeutics Inc. Option exercise +40,000 $10.48 $419,200
Sep 30, 2024 Travere Therapeutics Inc. Open-market sale −40,000 $14.06 $562,400

Questions about Jeffrey A. Meckler

What boards is Jeffrey A. Meckler on?

Jeffrey A. Meckler sits on the boards of Indaptus Therapeutics Inc. and Travere Therapeutics Inc.

What company is Jeffrey A. Meckler the CEO of?

Jeffrey A. Meckler is CEO and Director of Indaptus Therapeutics Inc.

How long has Jeffrey A. Meckler served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.